Continuous activation of the BCR leads to the apoptosis-resistant CLL cells, and overexpression of the antiapoptotic proteins XIAP, MCL-1, and BCL-XL (91). The gene discussed is BCL2L1; the disease is B-cell chronic lymphocytic leukemia.